Gi-1/Gi-2-dependent signaling by single-transmembrane natriuretic peptide clearance receptor

被引:112
作者
Murthy, KS
Teng, BQ
Zhou, H
Jin, JG
Grider, JR
Makhlouf, GM
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2000年 / 278卷 / 06期
关键词
G protein; smooth muscle; vasoactive intestinal peptide; signal transduction; phosphoinositide metabolism; phospholipase C;
D O I
10.1152/ajpgi.2000.278.6.G974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Single-transmembrane natriuretic peptide clearance receptor (NPR-C), which is devoid of a cytoplasmic guanylyl cyclase domain, interacts with pertussis toxin (PTx)-sensitive G proteins to activate endothelial nitric oxide synthase (eNOS) expressed in gastrointestinal smooth muscle cells. We examined the ability of NPR-C to activate other effector enzymes in eNOS-deficient tenia coli smooth muscle cells; these cells expressed NPR-C and NPR-B but not NPR-A. Atrial natriuretic peptide (ANP), the selective NPR-C ligand cANP-(4-23), and vasoactive intestinal peptide (VIP) inhibited I-125-ANP and I-125-VIP binding to muscle membranes in a pattern indicating high-affinity binding to NPR-C. Interaction of VIP with NPR-C was confirmed by its ability to inhibit I-125-ANP binding to membranes of NPR-C-transfected COS-1 cells. In tenia muscle cells, all ligands selectively activated G(i-1) and G(i-2); VIP also activated G(s) via VIP2 receptors. All ligands stimulated phosphoinositide hydrolysis, which was inhibited by ANP-(1-11), PTx, and antibodies to phospholipase C-beta 3 (PLC-beta 3) and G beta. cANP-(4-23) contracted tenia muscle cells; contraction was blocked by U-73122 and PTx and by antibodies to PLC-beta 3 and G beta in intact and permeabilized muscle cells, respectively. VIP and ANP contracted muscle cells only after inhibition of cAMP- and cGMP-dependent protein kinases. ANP and cANP-(4-23) inhibited forskolin-stimulated cAMP in a PTx-sensitive fashion. We conclude that NPR-C is coupled to activation of PLC-beta 3 via beta gamma-subunits of G(i-1) and G(i-2) and to inhibition of adenylyl cyclase via alpha-subunits.
引用
收藏
页码:G974 / G980
页数:7
相关论文
共 32 条
[1]   INTERACTION BETWEEN ATRIAL-NATRIURETIC-PEPTIDE AND VASOACTIVE-INTESTINAL-PEPTIDE IN GUINEA-PIG CECAL SMOOTH-MUSCLE [J].
AKIHO, H ;
CHIJIIWA, Y ;
OKABE, H ;
HARADA, N ;
NAWATA, H .
GASTROENTEROLOGY, 1995, 109 (04) :1105-1112
[2]   Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase - Involvement of a pertussis toxin-sensitive G protein [J].
AnandSrivastava, MB ;
Sehl, PD ;
Lowe, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19324-19329
[3]   THE PRESENCE OF ATRIAL-NATRIURETIC-FACTOR RECEPTORS OF ANF-R2 SUBTYPE IN RAT PLATELETS - COUPLING TO ADENYLATE-CYCLASE CYCLIC-AMP SIGNAL-TRANSDUCTION SYSTEM [J].
ANANDSRIVASTAVA, MB ;
GUTKOWSKA, J ;
CANTIN, M .
BIOCHEMICAL JOURNAL, 1991, 278 :211-217
[4]  
ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566
[5]  
ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455
[6]   Atrial natriuretic factor-induced amylase output in the rat parotid gland appears to be mediated by the inositol phosphate pathway [J].
Bianciotti, LG ;
Vatta, MS ;
Elverdin, JC ;
di Carlo, MB ;
Negri, G ;
Fernandez, BE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :123-128
[7]   EXPRESSION OF FUNCTIONAL RECEPTORS FOR VASOACTIVE-INTESTINAL-PEPTIDE IN FRESHLY ISOLATED AND CULTURED GASTRIC MUSCLE-CELLS [J].
CHIJIIWA, Y ;
MURTHY, KS ;
GRIDER, JR ;
MAKHLOUF, GM .
REGULATORY PEPTIDES, 1993, 47 (03) :223-232
[8]   THE FAMILY OF GUANYLYL CYCLASE RECEPTORS AND THEIR LIGANDS [J].
DREWETT, JG ;
GARBERS, DL .
ENDOCRINE REVIEWS, 1994, 15 (02) :135-162
[9]  
FULLER F, 1988, J BIOL CHEM, V263, P9395
[10]   STIMULATORY EFFECTS OF ATRIAL NATRIURETIC FACTOR ON PHOSPHOINOSITIDE HYDROLYSIS IN CULTURED BOVINE AORTIC SMOOTH-MUSCLE CELLS [J].
HIRATA, M ;
CHANG, CH ;
MURAD, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1010 (03) :346-351